Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 192-206

  Rühlmann, Andreas ^a   Nordheim, Alfred ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; TRANSCRIPTION FACTOR;

ALLOGRAFT; CELL COMMUNICATION; GENE CONTROL; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 2642631745     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80040-X     Document Type: Article

References (143)

1. BOREL, J. F., C. FEURER, H. U. GUBLER, and H. STAHELIN. 1976. Biological effects of cyclosporin A: A new antilymphocyte agent. Agents Action 6: 468.
2. KINO, T., H. HATANAKA, M. HASHIMOTO, M. NISHIYAMA, T. GOTO, M. OKUHARA, M. KOHSAKA, H. AOKI, and H. IMANAKA. 1987. FK506, a novel immunosuppressant isolated from Streptomyces. I. Fermentation, isolation, physico-chemical and biological characteristics. J. Antibiot. 40: 1249.
3. THOMSON, A. W. 1990. FK506 enters the clinic. Immunol. Today 11: 35.
4. KAHAN, B. D. 1993. Cyclosporin: The base for immunosuppressive therapy-present and future. Transplant. Proc. 25: 508.
5. STARZL, T. E. 1993. FK506 versus Cyclosporin. Transplant. Proc. 25: 511.
6. RAO, A. 1995. NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J. Leukoc. Biol. 57: 536.
7. SIKORSKI, R. S., M. S. BOGUSKI, M. GOEBL, and P. HIETER. 1990. A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60: 307.
8. SCHREIBER, S. L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283.
9. BRAM, R. J., D. T. HUNG, P. K. MARTIN, S. L. SCHREIBER, and G. R. CRABTREE. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13: 4760.
10. KRONKE, M., W. J. LEONARD, J. M. DEPPER, S. K. ARYA, F. WONG-STAAL, R. C. GALLO, T. A. WALDMANN, and W. C. GREENE. 1984. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 81: 5214.
11. FRIEDMAN, J. and I. WEISSMAN. 1991. Two cytoplasmatic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 66: 799.
12. LIU, J., J. D. J. FARMER, W. S. LANE, J. FRIEDMAN, I. WEISSMAN, and S. L. SCHREIBER. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807.
13. CLIPSTONE, N. A., and G. R. CRABTREE. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695.
14. FLANAGAN, W. M., B. CORTHESY, R. J. BRAM, and G. R. CRABTREE. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352: 803.
15. JAIN, J., P. G. MCCAFFREY, V. E. VALGE-ARCHER, and A. RAO. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356: 801.
16. JAIN, J., P. G. MCCAFFREY, Z. MINER, T. K. KERPPOLA, J. N. LAMBERT, G. L. VERDINE, T. CURRAN, and A. RAO. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352.
17. O'KEEFE, S. J., J. TAMURA, R. L. KINCAID, M. J. TOCCI, and E. A. O'NEILL. 1992. FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692.
18. ZHU, D., M. E. CARDENAS, and J. HEITMAN. 1996. Calcineurin mutants render T lymphocytes resistant to cyclosporin A. Mol. Pharmacol. 50: 506.
19. SVENSSON, U., E. HOLST, and R. SUNDLER. 1995. Cyclosporin-sensitive expression of cytokine mRNA in mouse macrophages responding to bacteria. Mol. Immunol. 32: 157.
20. MORI, A., M. SUKO, Y. NISHIZAKI, O. KAMINUMA, S. KOBAYASHI, G. MATSUZAKI, K. YAMAMOTO, K. ITO, N. TSURUOKA, and H. OKUDAIRA. 1995. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7: 449.
21. SCHANDENE, L., C. ALONSO-VEGA, F. WILLEMS, C. GERARD, A. DELVAUX, T. VELU, R. DEVOS, M. DE-BOER, and M. GOLDMAN. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 152: 4368.
22. GHOSH, P., A. SICA, M. CIPPITELLI, J. SUBLESKI, R. LAHESMAA, H. A. YOUNG, and N. R. RICE. 1996. Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. J. Biol. Chem. 271: 7700.
23. HUGHES, C. C. W., and J. POBER. 1996. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 271: 5369.
24. MARUMO, T., T. NAKAKI, K. HISHIKAWA, S. H. R. KATO, and T. SARUTA. 1995. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 25: 764.
25. LAWSON, M. A., and F. R. MAXFIELD. 1995. Ca(2+)-and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 376: 75.
26. SU, B., E. JACINTO, M. HIBI, T. KALLUNKI, M. KARIN, and Y. BEN-NERIAH. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77: 727.
27. SIGAL, N. H., and F. J. DUMONT. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann. Rev. Immunol. 10: 519.
28. SABATINI, D. M., H. ERDJUMENT-BROMAGE, M. LUI, P. TEMPST, and S. H. SNYDER. 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78: 35.
29. BROWN, E. J., M. W. ALBERS, T. B. SHIN, K. ICHIKAWA, C. T. KEITH, W. S. LANE, and S. L. SCHREIBER. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756.
30. CHEN Y., H. CHEN, A. E. RHOAD, L. WARNER, T. J. CAGGIANO, A. FAILLI, H. ZHANG, C. L. HSIAO, K. NAKANISHI, and K. L. MOLNAR-KIMBER. 1994. A putative sirolimus (rapamycin) effector protein. Biochem Biophys. Res. Commun. 203: 1.
31. CHIU, M. I., H. KATZ, and V. BERLIN. 1994. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA 91: 12574.
32. FRANKE, E. K., and J. LUBAN. 1996. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222: 279.
33. BRAATEN, D., C. ABERHAM, E. K. FRANKE, L. YIN, W. PHARES, and J. LUBAN. 1996. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J. Virol. 70: 5170.
34. YANG, W. M., C. J. INOUYE, and E. SETO. 1995. Cyclophilin A and FKBP12 interact with yy1 and alter its transcriptional activity. J. Biol. Chem. 270: 15187.
35. WANG, T., B. Y. LI, P. D. DANIELSON, P. C. SHAH, S. ROCKWELL, R. J. LECHLEIDER, J. MARTIN, T. MANGANARO, and P. K. DONAHOE. 1996. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86: 435.
36. JAYARAMAN, T., A.-M. B. BRILLANTES, A. P. TIMERMAN, H. ERDJUMENT-BROMAGE, S. FLEISCHER, P. TEMPST, and A. R. MARKS. 1992. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267: 9474.
37. LAM, E., M. M. MARTIN, A. P. TIMERMAN, C. SABERS, S. FLEISCHER, T. LUKAS, R. T. ABRAHAM, S. J. O'KEEFE, E. A. O'NEILL, and G. J. WIEDERRECHT. 1995. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J. Biol. Chem. 270: 26511.
38. CAMERON, A. M., J. P. STEINER, A. J. ROSKAMS, S. M. ALI, G. V. RONNETT, and S. H. SNYDER. 1995. Calcineurin associated with the inositol 1,4,5-trisphospate receptor-FKBP12 complex modulates Ca2+ flux. Cell 83: 463.
39. OWENS-GRILLO, J. K., K. HOFFMANN, K. A. HUTCHISON, A. W. YEM, M. R. J. DEIBEL, R. E. HANDSCHUMACHER, and W. R. PRATT. 1995. The cyclosporine A-binding immunophilin Cyp-40 and the FK506-binding immunophilin Hsp56 bind to a common site on Hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270: 20479.
40. CHAMBRAUD, B., C. RADANYI, J. H. CAMONIS, K. SHAZAND, K. RAJKOWSKI, and E. E. BAULIEU. 1996. FAP48, a new protein that form specific complexes with both immunophilins FKB59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin. J. Biol. Chem. 271: 32923.
41. FISCHER, G. 1994. Über Peptidyl-Prolyl-cis/trans-Isomerasen und ihre Effektoren. Angew. Chem. 106: 1479.
42. LODISH, H. F., and N. KONG. 1991. Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. J. Biol. Chem. 266: 14835.
43. STEINMANN, B., P. BRUCKNER, and A. SUPERTI-FURGA. 1991. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J. Biol. Chem. 266: 1299.
44. HANDSCHUMACHER, R., M. HARDING, J. RICE, and R. DRUGGE. 1984. Cyclophilin: a specific binding protein for cyclosporin A. Science 266: 544.
45. HAENDLER, B., R. HOFER-WARBINEK, and E. HOFER. 1987. Complementary DNA for human T-cell cyclophilin. EMBO J. 6: 947.
46. TAKAHASHI, N., T. HAYANO, and M. SUZUKI. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosproin A-binding protein cyclophilin. Nature 337: 473.
47. FISCHER, G., B. WITTMANN-LIEBOLD, K. LANG, T. KIEFHABER, and F. SCHMID. 1989. Cyclophilin and peptidyl-prolyl cis/trans isomerase are probably identical proteins. Nature 337: 476.
48. PRICE, E. R., L. D. ZYDOWSKY, M. JIN, C. H. BAKER, F. D. MCKEON, and C. T. WALSH. 1991. Human Cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc. Natl. Acad. Sci. USA 88: 1903.
49. SPIK, G., B. HAENDLER, O. DELMAS, C. MARILLER, M. CHAMOUX, P. MAES, A. TARTAR, J. MONTREUIL, K. STEDMAN, and H. P. KOCHER. 1991. A novel secreted cyclophilin-like protein (SCYLP). J. Biol. Chem. 266: 10735.
50. BERGSMA, D. J., C. EDER, M. GROSS, H. KERSTEN, D. SYLVESTER, E. APPELBAUM, D. CUSIMANO, G. P. LIVI, M. M. MCLAUGHLIN, K. KASYAN, et al. 1991. The cyclopholin multigene family of peptidyl-prolyl isomerases. J. Biol. Che, 266: 23204.
51. KIEFER, L. J., T. W. SENG, W. LI, D. G. OSTERMAN, R. E. HANDSCHUMACHER, and R. M. BAYNEY. 1993. Cyclophilin-40, a protein with homology to the p59 component of the steroid receptor complex. J. Biol. Chem. 268: 12303.
52. ANDERSON, S. K., K. S. GALLINGER, J. RODER, J. FREY, H. A. YOUNG, and J. R. ORTALDO. 1993. A cyclophilin-related protein involved in the function of natural killer cells. Proc. Natl. Acad. Sci. USA 90: 542.
53. CACALANO, N. A., B.-X. CHEN, W. L. CLEVELAND, and B. F. ERLANGER. 1992. Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. Proc. Natl. Acad. Sci. USA 89: 4353.
54. MATSUSHIMA, K., K. MORISHITA, Y. YOSHIMURA, S. LAVU, Y. KOBAYASHI, W. LEW, E. APPELLA, H. F. KUNG, E. J. LEONARD, and J. J. OPPENHEIM. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167: 1883.
55. BANG, H., K. BRUNE, C. NAGER, and U. FEIGE. 1993. Interleukin-8 is a cyclosporin A binding protein. Experientia 49: 533.
56. HARDING, M., A. GALAT, D. UEHLING, and S. SCHREIBER. 1989. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758.
57. SIEKIERKA, J., S. HUNG, M. POE, C. LIN, and N. SIGAL. 1989. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341: 755.
58. MAKI, N., F. SEKIGUCHI, J. NISHIMAKI, K. MIWA, T. HAYANO, N. TAKAHASHI, and M. SUZUKI. 1990. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. Proc-Natl-Acad-Sci-U-S-A 87: 5440.
59. STADAERT, R. F., A. GALAT, G. L. VERDINE, and S. L. SCHREIBER. 1990. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature 346: 671.
60. BANG, H., W. MÜLLER, M. HANS, K. BRUNE, and D. SWANDULLA. 1995. Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12. Proc. Natl. Acad. Sci. USA 92: 3435.
61. CUNNINGHAM, E. B. 1995. The human erythrocyte membrane contains a novel 12-kDa inositolphospate-binding protein that is an immunophilin. Biochem. Biophys. Res. Commun. 215: 212.
62. NIGAM, S. K., Y. J. JIN, M. J. JIN, K. T. BUSH, B. E. BIERER, and S. J. BURAKOFF. 1993. Localization of the FK506-binding protein, FKBP13, to the lumen of the endoplasmatic reticulum. Biochem. J. 294: 511.
63. JIN, Y. J., S. BURAKOFF, J., and B. E. BIERER. 1992. Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J. Biol. Chem. 267: 10942.
64. HUNG, D. T., and S. L. SCHREIBER. 1992. cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. Biochem. Biophys. Res. Commun. 184: 733.
65. JIN, Y.-J., and S. J. BURAKOFF. 1993. The 25-kDa FK506 binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. Proc. Natl. Acad. Sci. USA 90: 7769.
66. LAM, E., M. MARTIN, and G. WIEDERRECHT. 1995. Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat mofifs. Gene 160: 297.
67. PEATTIE, D. A., M. W. HARDING, M. A. FLEMING, M. T. DECENZO, J. A. LIPPKE, D. J. LIVINGSTONE, and M. BEASUTTI. 1992. Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. USA 89: 10974.
68. LEBEAU, M.-C., N. MASSOL, J. HERRIK, L. E. FABER, J.-M. RENOIR, C. RADANYI, and E.-E. BAULIEU. 1992. P59, an Hsp90-binding protein. J. Biol. Chem. 267: 4281.
69. YEM, A. W., A. G. TOMASSELI, R. L. HEINRIKSON, H. ZURCHER-NEELY, V. A. RUFF, R. A. JOHNSON, and M. R. J. DEIBEL. 1992. The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J. Biol. Chem. 267: 2868.
70. NAIR, S. C., R. A. RIMERMAN, E. J. TORAN, S. CHEN, V. PRAPAPANICH, R. N. BUTTS, and D. F. SMITH. 1997. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol. Cell. Biol. 17: 594.
71. FRANTZ, B., E. C. NORDBY, G. BREN, N. STEFFAN, C. V. PAYA, R. L. KINCAID, M. J. TOCCI, S. J. O'KEEF, and E. A. O'NEILL. 1994. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, and inhibitor of NF-kappa B. EMBO J. 13: 861.
72. DAWSON, T. M., J. P. STEINER, V. L. DAWSON, J. L. DINERMAN, G. R. UHL, and S. H. SNYDER. 1993. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 9808.
73. COGHLAN, V. M., B. A. PERRINO, M. HOWARD, L. K. LANGEBERG, J. B. HICKS, W. M. GALLATIN, and J. D. SCOTT. 1995. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267: 108.
74. SHIH, M., and C. C. MALBON. 1996. Protein kinase C deficiency blocks recovery from agonist-induced desensitization. J. Biol. Chem. 271: 21478.
75. MUELLER, D. L., S. SEIFFERT, F. W., and T. W. BEHRENS. 1996. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells. J. Immunol. 156: 1764.
76. ANDERSON, J. S., M. TEUTSCH, Z. DONG, and H. H. WORTIS. 1996. An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93: 10966.
77. LIU, S., P. LIU, A. BORRAS, T. CHATILA, and S. H. SPECK. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16: 143.
78. TEUTSCH, M., M. HIGER, D. WANG, and H. W. WORTIS. 1995. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. Int. Immunol. 7: 381.
79. WARE, R. E., M. K. HART, and B. F. HAYNES. 1991. Induction of T cell CD7 gene transcription by nonmitogenic ionomycin-induced transmembrane calcium flux. J. Immunol. 147: 2787.
80. FULEIHAN, R., N. RAMESH, A. HORNER, D. AHERN, P. J. BELSHAW, D. G. ALBERG, I. STAMENKOVIC, W. HARMON, and R. S. GEHA. 1994. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93: 1315.
81. WANG, C. R., K. HASHIMOTO, S. KUBO, T. YOKOCHI, M. KUBO, M. SUZUKI, K. SUZUKI, T. TADA, and T. NAKAYAMA. 1995. T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. J. Exp. Med. 181: 927.
82. OYAIZU, N., T. W. MCCLOSKEY, S. THAN, R. HU, V. S. KALYANARAMAN, and S. PAHWA. 1994. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 84: 2622.
83. ANEL, A., M. BUFERNE, C. BOYER, A. M. SCHMITT-VERHULST, and P. GOLSTEIN. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24: 2469.
84. AJCHENBAUM, F., K. ANDO, J. A. DE CAPRIO, and J. D. GRIFFIN. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268: 4113.
85. METCALFE, S. M., and F. M. RICHARDS. 1990. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 49: 798.
86. MAGES, H. W., T. STAMMINGER, O. RILKE, R. BRAVO, and R. A. KROCZEK. 1993. Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells. Int. Immunol. 5: 63.
87. KAUFMANN, Y., T. SILVERMAN, B. Z. LEVI, and K. OZATO. 1987. Induction of c-ets and c-fos gene expression upon antigenic stimulation of a T cell hybridoma with inducible cytolytic capacity. J. Exp. Med. 166: 810.
88. FURUE, M., S. I. KATZ, Y. KAWAKAMI, and T. KAWAKAMI. 1990. Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine. J. Immunol. 144: 736.
89. SCHWANINGER, M., R. BLUME, E. OETJEN, G. LUX, and W. KNEPEL. 1993. Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J. Biol. Chem. 268: 23111.
90. TOCCI, M. J., D. A. MATKOVICH, K. A. COLLIER, P. KWOK, F. DUMONT, S. LIN, D. S., J. J. SIEKIERKA, J. CHIN, and N. I. HUTCHINSON. 1989. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143: 718.
91. ZIFPEL, P. F., A. BIALONSKI, and C. SKERKA. 1991. Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A. Biochem-Biophys-Res-Commun. 181: 179.
92. WISKOCIL, R., A. WEISS, J. IMBODEN, R. KAMIN-LEWIS, and J. STOBO. 1985. Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes. J. Immunol. 134: 1599.
93. REDMON, J. B., L. K. OLSON, M. B. ARMSTRONG, M. J. GREENE, and R. P. ROBERTSON. 1996. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J. Clin. Invest. 98: 2786.
94. REED, J. C., M. B. PRYSTOWSKY, and P. C. NOWELL. 1988. Regulation of gene expression in lectin-stimulated or lymphokine-stimulated T lymphocytes. Effects of cyclosporine. Transplantation 46: 85.
95. GRANELLI-PIPERNO, A., M. KEANE, and R. M. STEINMAN. 1988. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation 46: 53.
96. WILLIAMS, C. M., and J. W. COLEMAN. 1995. Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 86: 244.
97. OKAMOTO, S., N. MUKAIDA, K. YASUMOTO, N. RICE, Y. ISHIKAWA, H. HORIGUCHI, S. MURAKAMI, and K. MATSUSHIMA. 1994. The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J. Biol. Chem. 269: 8582.
98. REED, J. C., P. C. NOWELL, and R. G. HOOVER. 1985. Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation. Proc. Natl. Acad. Sci. USA 82: 4221.
99. REED, J. C., A. H. ABIDI, A. J. D., R. G. HOOVER, R. J. ROBB, and P. C. NOWELL. 1986. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J. Immunol. 137: 150.
100. DOKTER, W. H., P. BORGER, D. HENDRIKS, I. VAN-DER-HORST, M. R. HALIE, and E. VELLENGA. 1992. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level. Blood 80: 2721.
101. RUMSAENG, V., H. VLIAGOFTIS, C. K. OH, and D. D. METCALFE. 1997. Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin. A. J. Immunol. 158: 1353.
102. GONZALEZ-CUADRADO, S., C. BUSTOS, M. RUIZ-ORTEGA, A. ORTIZ, C. GUIJARRO, J. J. PLAZA, and J. EGIDO. 1996. Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin. Exp. Immunol. 106: 518.
103. HEDVAT, C. V., and S. G. IRVING. 1995. The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor. Mol. Endocrinol. 9: 1682.
104. GOLAY, J., G. CUSMANO, and M. INTRONA. 1992. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149: 300.
105. REED, J. C., D. E. SABATH, R. G. HOOVER, and M. B. PRYSTOWSKY. 1985. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol. Cell. Biol. 5: 3361.
106. MCCAFFREY, P. G., P. K., KIM, V. E. VALGE-ARCHER, R. SEN, and A. RAO. 1994. Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells. Nucleic Acids Res. 22: 2134.
107. ENSLEN, H., and T. R. SODERLING. 1994. Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J. Biol. Chem. 269: 20872.
108. KANG, S. M., W. TSANG, S. DOLL, P. SCHERLE, H. S. KO, A. C. TRAN, M. J. LENARDO, and L. M. STAUDT. 1992. Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Mol. Cell. Biol. 12: 3149.
109. ZIPFEL, P. F., J. BALKE, S. G. IRVING, K. KELLY, and U. SIEBENLIST. 1989. Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J. Immunol. 142: 1582.
110. STROEBEL, M., and M. GOPPELT-STRUBE. 1994. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J. Biol. Chem. 269: 22952.
111. WIEDER, K. J., G. WALZ, B. ZANKER, P. SEHAJPAL, V. K. SHARMA, E. SKOLNIK, T. B. STROM, and M. SUTHANTHIRAN. 1990. Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction. Cell. Immunol. 128: 41.
112. BURD, P. R., G. J. FREEMAN, S. D. WILSON, M. BERMAN, R. DEKRUYFF, P. R. BILLINGS, and DORF-ME. 1987. Cloning and characterization of a novel T cell activation gene. J. Immunol. 139: 3126.
113. WILKINSON, M. F., and C. L. MACLEOD. 1988. Complex regulation of the T cell receptor alpha gene: three different modes of triggering induction. Eur. J. Immunol. 18: 873.
114. WENG, N. P., B. L. LEVINE, C. H. JUNE, and R. J. HODES. 1996. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183: 2471.
115. HÖLSCHERMANN, H., F. DÜRFELD, U. MAUS, A. BIERHAUS, K. HEIDINGE, J. LOHMEYER, P. P. NAWROTH, H. TILLMANNS, and W. HABERBOSCH. 1996. Cyclosporine a inhibits tissue factor expression in monocytes/macrophages. Blood 88: 3837.
116. TEOFOLI, P., A. MANCINI, and T. LOTTI. 1996. Cyclosporine A inhibits tPA mRNA transcription in A431 cell line. Skin. Pharmacol. 9: 137.
117. SCHMANDT, R., M. HILL, A. AMENDOLA, G. B. MILLS, and D. HOGG. 1994. IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression. J. Immunol. 152: 96.
118. NILLER, H. H., and L. HENNIGHAUSEN. 1990. Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J. Virol. 64: 2388.
119. KELLEHER, C. A., D. A. WILKINSON, J. D. FREEMAN, D. L. MAGER, and E. W. GELFAND. 1996. Expression of novel-transposon-containing mRNAs in human cells. J. Gen. Virol. 77: 1101.
120. TONG-STARKESEN, S. E., P. A. LUCIW, and B. M. PETERLIN. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142: 702.
121. COPELAND, K. F., A. G. HAAKSMA, J. GOUDSMIT, and J. L. HEENEY. 1994. Calcium-mediated inhibition of phorbol ester and Tax trans-activation of the human T cell leukaemia virus type 1. J. Gen. Virol. 75: 1623.
122. SHAW, J., K. MEEROVITCH, J. F. ELLIOT, R. C. BLEACKLEY, and V. PAETKAU. 1987. Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes. Mol. Immunol. 24: 409.
123. MILLER, C. L., R. GARNER, and V. PAETKAU. 1992. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Moll. Cell. Biol. 12: 3262.
124. GENESTIER, L., N. BONNEFOY-BERARD, J. P. ROUAULT, M. FLACHER, and J. P. REVILLARD. 1995. Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int. Immunol. 7: 533.
125. WOLF, G., P. D. KILLEN, and E. G. NEILSON. 1990. Cyclosporin A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cells. J. Am. Soc. Nephrol. 1: 918.
126. LOHI, J., V. M. KAHARI, and J. KESKI-OJA. 1994. Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J. Invest. Dermatol. 102: 938.
127. MARSEN, T. A., M. S. SIMONSON, and M. J. DUNN. 1995. Thrombin-mediated ET-1 gene regulation involves CaM kinases and calcineurin in human endothelial cells. J. Cardiovasc. Pharmacol. 26 Suppl 3: S1.
128. FRISHBERG, Y., C. M. MEYERS, and C. J. KELLY. 1996. Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int. 50: 45.
129. HAN, C. W., M. IMAMURA, S. HASHINO, X. ZHU, J. TANAKA, K. IMAI, T. MATSUDAIRA, and S. ASANO. 1995. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. Bone Marrow. Transplant. 15: 733.
130. SU, Q., H. P. EUGSTER, B. RYFFEL, and F. J. DUMONT. 1996. Cyclosporin A enhances the calcium-dependent induction of AP-1 complex and c-fos mRNA in a T cell lymphoma. Biochem. Biophys. Res. Commun. 229: 249.
131. ALTMEYER, A., M. J. STARUCH, P. A. FISCHER, P. L. DURETTE, M. J. TOCCI, N. H. SIGAL, and F. J. DUMONT. 1991. Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin. Int-J-Immunopharmacol. 13: 187.
132. KALDJIAN, E. P., and L. M. STOOLMAN. 1995. Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium-and protein kinase C-dependent signaling pathways. J. Immunol. 154: 4351.
133. LI, B., P. K., SEHAJPAL, A. KHANNA, H. VLASSARA, A. CERAMI, K. H. STENZEL, and M. SUTHANTHIRAN. 1991. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J. Exp. Med. 174: 1259.
134. PAILLARD, F., and C. VAQUERO. 1991. Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional and post-transcriptional mechanisms. Nucleic-Acids-Res. 19: 4655.
135. NAKAYAMA, K., and H. NAKAUCHI. 1993. Cyclosporin A inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation. Int. Immunol. 5: 419.
136. SHIBASAKI, F., E. KONDO, T. AKAGI, and F. MCKEON. 1997. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 368: 728.
137. MATA, M., S. E. MERRITT, G. FAN, G. G. YU, and L. B. HOLZMAN. 1996. Characterization of dual leucine zipper-bearing kinase, a mixed lineage kinase present in synaptic terminals whose phosphorylation state is regulated by membrane depolarization via calcineurin. J. Biol. Chem. 271: 1688.
138. LIU, J. P., A. T. SIM, and P. J. ROBINSON. 1994. Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science 265: 970.
139. CHAKRAVARTHY, B. R., R. J. ISAACS, P. MORLEY, and J. F. WHITFIELD. 1995. Ca2+ x calmodulin prevents myristoylated alanine-rich kinase C substrate protein phosphorylation by protein kinase Cs in C6 rat glioma cells. J. Biol. Chem. 270: 24911.
140. CHEN, T. C., B. LAW, T. KONDRATYUK, and S. ROSSIE. 1995. Identification of soluble protein phosphatase that dephosphorylate voltage-sensitive sodium channels in rat brain. J. Biol. Chem. 270: 7750.
141. LIEBERMAN, D. N., and I. MODY. 1994. Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature 369: 235.
142. STEINER, J. P., T. M. DAWSON, M. FOTUHI, and S. H. SNYDER. 1996. Immunophilin regulation of neurotransmitter release. Mol. Med. 2: 325.
143. NORMAN, S. G., and G. V. JOHNSON. 1994. Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. Neurochem. Res. 19: 1151.